| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |